MENJUGATE 10 micrograms, suspension for injection in a pre-filled syringe. vaccine conjugate meningococcal groupe c syringe, 0.6 ml
Active ingredients: OLIGOSIDE DE NEISSERIA MENINGITIDIS (SOUCHE C11) GROUPE C CONJUGUÉ À LA PROTÉINE CRM-197 DE CORYNEBACTERIUM DIPHTERIAE, PROTÉINE DIPHTÉRIQUE CRM197
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 0.6 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MENJUGATE 10 microgrammes, suspension injectable en seringue préremplie. Vaccin conjugué méningococcique groupe C
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,6 ml
- Marketing authorisation holder
- GSK VACCINES SRL (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Sept 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63301248CIP73001760CIP133400930017609Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROTÉINE DIPHTÉRIQUE CRM197suspension | 12,5 - 25 microgrammes · une dose de 0,5 ml | SA |
| OLIGOSIDE DE NEISSERIA MENINGITIDIS (SOUCHE C11) GROUPE C CONJUGUÉ À LA PROTÉINE CRM-197 DE CORYNEBACTERIUM DIPHTERIAEsuspension | 10 microgrammes · une dose de 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.